STRUCTURAL PEPTIDE INHIBITORS OF α-SYNUCLEIN AGGREGATION Russian patent published in 2022 - IPC C07K7/08 C07K7/02 C07K14/47 A61K38/00 G01N33/68 A61P25/16 A61P25/28 

Abstract RU 2766711 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to the field of biotechnology, specifically to inhibitor peptides of α-synuclein; it can be used in medicine for inhibiting α-synuclein aggregation. Inhibitor peptide up to 30 amino acids long is proposed, containing GAVVWGVTAVKK or RAVVTGVTAVAE. At least one of amino acids in inhibitor peptide is not found in nature amino acid selected from D-amino acid or amino acid containing a fragment of N-methyl group. Inhibitor peptide also contains a heterologous peptide tag to increase its solubility, relieve its monitoring and/or peptide entry to a mammalian cell.

EFFECT: invention provides for inhibiting the formation, fibril priming, and distribution of alpha-synuclein aggregates.

4 cl, 7 dwg, 4 tbl, 3 ex

Similar patents RU2766711C2

Title Year Author Number
EGFL6-SPECIFIC MONOCLONAL ANTIBODIES AND THEIR APPLICATION METHODS 2017
  • Zhang, Ningyan
  • An, Zhiqiang
  • Sood, Anil, K.
RU2779902C2
CHIMERIC HUMAN MESOTHELIOGEN ANTIGEN RECEPTORS AND USE THEREOF 2014
  • Bitti Gregori
  • Engels Boris
  • Idamakanti Neeradzha
  • Dzhun Karl Kh.
  • Lev Andreas
  • Sun Khuejtszyuan
  • U Tsilun
RU2714902C2
COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN EXPRESSION 2017
  • Golosov, Andrei
  • Guimaraes, Carla
  • Motz, Gregory
  • Milone, Michael
  • Ellebrecht, Christoph, T.
  • Payne, Aimee, S.
RU2795467C2
DNA ANTIBODY CONSTRUCTIONS FOR USE AGAINST LYME DISEASE 2017
  • Weiner, David, B.
  • Flingai, Seleeke
RU2813829C2
COMPOSITIONS AND METHODS OF GENE EDITING 2019
  • Chen, Jin
  • Gilbert, Luke
  • Nunez, James
  • Weissman, Jonathan
RU2804665C2
GLYCAN-DEPENDENT IMMUNOTHERAPY MOLECULES 2016
  • Demetriou Majkl
  • Chzhou Rejmond Venkhou
RU2754661C2
TREATMENT OF MALIGNANT NEOPLASM USING HUMANIZED CHIMERIC ANTIGEN RECEPTOR AGAINST BCMA 2015
  • Brogdon, Jennifer
  • Choi, Eugene
  • Ebersbach, Hilmar
  • Glass, David
  • Huet, Heather
  • June, Carl, H.
  • Mannick, Joan
  • Milone, Michael, C.
  • Murphy, Leon
  • Plesa, Gabriela
  • Richardson, Celeste
  • Ruella, Marco
  • Singh, Reshma
  • Wang, Yongqiang
  • Wu, Qilong
RU2751660C2
CHIMERIC ANTIGENIC (CAR) RECEPTOR AGAINST CD123 FOR USE IN TREATING MALIGNANT TUMORS 2015
  • Brogdon, Jennifer
  • Gill, Saar
  • Glass, David
  • Kenderian, Saad
  • Loew, Andreas
  • Mannick, Joan
  • Milone, Michael
  • Murphy, Leon
  • Porter, David, L.
  • Ruella, Marco
  • Wang, Yongqiang
  • Wu, Qilong
  • Zhang, Jiquan
RU2724999C2
ANTI-C5 ANTIBODIES AND THEIR USE 2018
  • Song, Wenchao
  • Sato, Sayaka
  • Miwa, Takashi
  • Guillipalli, Damodar
RU2774716C2
CHIMERIC ANTIGEN RECEPTORS FOR CANCER TREATMENT 2017
  • Brannetti, Barbara
  • Brogdon, Dzhennifer
  • Engels, Boris
  • Granda, Brajan
  • Khuan, Lu
  • Lej, Min
  • Li, Na
  • Chzhan, Tszimin
  • Gimares, Karla
  • Dzhill, Saar
  • Ruella, Marko
  • Yang, Regina M.
RU2826270C2

RU 2 766 711 C2

Authors

Eisenberg, David S.

Sangwan, Smriti

Jiang, Lin

Dates

2022-03-15Published

2017-06-29Filed